Impact of the Timing of Metoprolol Administration during STEMI on Infarct Size and Ventricular Function

Journal of the American College of Cardiology

Volumn 67, Issue 18, 2016, Pages 2093-2104

  García Ruiz, Jose M ^a,b   Fernández Jiménez, Rodrigo ^a,c   García Alvarez, Ana ^a,d   Pizarro, Gonzalo ^a,e   Galán Arriola, Carlos ^a   Fernández Friera, Leticia ^a,f   Mateos, Alonso ^g,h   Nuno Ayala, Mario ^a   Aguero, Jaume ^a   Sánchez González, Javier ⁱ   García Prieto, Jaime ^a   López Melgar, Beatriz ^a,f   Martínez Tenorio, Pedro ^g   López Martín, Gonzalo J ^a   MacÍas, Angel ^a   Pérez Asenjo, Braulio ^a   Cabrera, José A ^e   Fernández Ortiz, Antonio ^a,c   Fuster, Valentín ^a,j   Ibáñez, Borja ^a,k  

^a CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^f Instituto de Salud Carlos III   (Spain)

^g Servicio de Urgencia Médica de Madrid SUMMA112   (Spain)

^h UNIVERSIDAD FRANCISCO DE VITORIA   (Spain)

ⁱ PHILIPS HEALTHCARE   (United States)

^j MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^k HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ   (Spain)

more..

Author keywords

cardiac magnetic resonance; cardioprotection; left ventricular ejection fraction; myocardial infarction; reperfusion injury

Indexed keywords

METOPROLOL; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT;

ACUTE DISEASE; ADULT; ANGIOPLASTY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CHRONIC DISEASE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTCOME ASSESSMENT; PIG; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT DURATION; VALIDATION PROCESS; ANIMAL; CINE MAGNETIC RESONANCE IMAGING; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DISEASE MODEL; DRUG ADMINISTRATION; DRUG EFFECTS; EMERGENCY HEALTH SERVICE; HEART STROKE VOLUME; HEART VENTRICLE REMODELING; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; ST ELEVATION MYOCARDIAL INFARCTION; TIME TO TREATMENT;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ANIMALS; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; EMERGENCY MEDICAL SERVICES; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING, CINE; MALE; METOPROLOL; MIDDLE AGED; MYOCARDIAL REPERFUSION; PERCUTANEOUS CORONARY INTERVENTION; ST ELEVATION MYOCARDIAL INFARCTION; STROKE VOLUME; SWINE; TIME-TO-TREATMENT; VENTRICULAR REMODELING;

EID: 84962092500     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.02.050     Document Type: Article

References (23)

1. P.T. O'Gara, F.G. Kushner, D.D. Ascheim, and et al. 2013 AHA guideline/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 61 2013 485 510
2. P.G. Steg, S.K. James, D. Atar, and et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Eur Heart J 33 2012 2569 2619
3. B. Ibanez, G. Heusch, M. Ovize, and F. Van de Werf Evolving therapies for myocardial ischemia/reperfusion injury J Am Coll Cardiol 65 2015 1454 1471
4. J. Lonborg, N. Vejlstrup, H. Kelbaek, and et al. Final infarct size measured by cardiovascular magnetic resonance in patients with ST elevation myocardial infarction predicts long-term clinical outcome: an observational study Eur Heart J Cardiovasc Imaging 14 2013 387 395
5. C.W. Yancy, M. Jessup, B. Bozkurt, and et al. 2013 AHA guideline/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 2013 e147 e239
6. B. Ibanez, C. Macaya, V. Sanchez-Brunete, and et al. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial Circulation 128 2013 1495 1503
7. G. Pizarro, L. Fernandez-Friera, V. Fuster, and et al. Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC Trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction) J Am Coll Cardiol 63 2014 2356 2362
8. B. Ibanez, V. Fuster, C. Macaya, and et al. Study design for the "effect of METOprolol in CARDioproteCtioN during an acute myocardial InfarCtion" (METOCARD-CNIC): a randomized, controlled parallel-group, observer-blinded clinical trial of early pre-reperfusion metoprolol administration in ST-segment elevation myocardial infarction Am Heart J 164 2012 473 480.e5
9. J. García-Prieto, J.M. García-Ruiz, D. Sanz-Rosa, and et al. β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes Basic Res Cardiol 109 2014 422
10. R. Fernandez-Jimenez, J. Sanchez-Gonzalez, J. Aguero, and et al. Myocardial edema after ischemia/reperfusion is not stable and follows a bimodal pattern: imaging and histological tissue characterization J Am Coll Cardiol 65 2015 315 323
11. R. Fernandez-Jimenez, J. Garcia-Prieto, J. Sanchez-Gonzalez, and et al. Pathophysiology underlying the bimodal edema phenomenon after myocardial ischemia/reperfusion J Am Coll Cardiol 66 2015 816 828
12. K.W. Kelley, S.E. Curtis, G.T. Marzan, and et al. Body surface area of female swine J Anim Sci 36 1973 927 930
13. B. Ibanez, S. Prat-Gonzalez, W.S. Speidl, and et al. Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance Circulation 115 2007 2909 2916
14. B. Ibanez, G. Cimmino, S. Prat-Gonzalez, and et al. The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusion Int J Cardiol 147 2011 428 432
15. K.L. Park, R.J. Goldberg, F.A. Anderson, and et al. Beta-blocker use in ST-segment elevation myocardial infarction in the reperfusion era (GRACE) Am J Med 127 2014 503 511
16. K.L. Woods, D. Ketley, A. Lowy, et al. for the European Secondary Prevention Study Group Beta-blockers and antithrombotic treatment for secondary prevention after acute myocardial infarction. Towards an understanding of factors influencing clinical practice Eur Heart J 19 1998 74 79
17. W.J. Rogers, L.J. Bowlby, N.C. Chandra, and et al. Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction Circulation 90 1994 2103 2114
18. Z.M. Chen, H.C. Pan, Y.P. Chen, and et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial Lancet 366 2005 1622 1632
19. A. Mateos, I. Garcia-Lunar, J.M. Garcia-Ruiz, and et al. Efficacy and safety of out-of-hospital intravenous metoprolol administration in anterior ST-segment elevation acute myocardial infarction: insights from the METOCARD-CNIC trial Ann Emerg Med 65 2015 318 324
20. V. Roolvink, S. Rasoul, J.P. Ottervanger, and et al. Rationale and design of a double-blind, multicenter, randomized, placebo-controlled clinical trial of early administration of intravenous beta-blockers in patients with ST-elevation myocardial infarction before primary percutaneous coronary intervention: EARLY beta-blocker administration before primary PCI in patients with ST-elevation myocardial infarction trial Am Heart J 168 2014 661 666
21. J. Garcia-Prieto, I. García-Lumar, M. Gomez-Parrizas, and et al. Metoprolol protects against AMI through the inhibition of psgl1-dependent neutrophil-platelet interaction Circulation 132 2015 A19308
22. S.P. Jones, X.L. Tang, Y. Guo, and et al. The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective Therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs Circ Res 116 2015 572 586
23. R. Fernandez-Jimenez, and B. Ibanez CAESAR: one step beyond in the construction of a translational bridge for cardioprotection Circ Res 116 2015 554 556